![]() Tissue Regenix Group Tissue Regenix uses its patented dCELL technology to address many clinical needs such as sports medicine, wound care and heart valve replacement. | ![]() Hanger Empowering human potential with innovative technologies, efficient and effective clinical solutions, and outstanding customer service. | |
Founding Date | Founding Date 2006 | Founding Date 1861 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Swillington, GB HQ Garforth, GB Universal City, US | Locations Austin, US HQ |
Employees | Employees 61 | Employees 4,600 |
Valuation ($) | Valuation ($) 51.4 m | Valuation ($) 724.6 m |
Financial | ||
Revenue (est.) | Revenue (est.) $31.8m (FY, 2024) | Revenue (est.) $1.1b (FY, 2021) |
Net income | Net income ($681k) (FY, 2024) | Net income $42m (FY, 2021) |

Empowering human potential with innovative technologies, efficient and effective clinical solutions, and outstanding customer service.
View company